DocWire News Editors

DocwireNews

Between 2000 and 2015, deaths from opioid prescriptions more than quadrupled, and evidence of long-term efficacy of opioids for chronic pain is limited. Researchers sought to quantify the healthcare resource utilization and direct costs among chronic and acute opioid users compared with those not on these medications. The results of the study were presented at the AMCP Annual Meeting during a poster session titled &ldquo;Healthcare Resource Utilization and Costs in Chronic and Acute Opioid Users over 2 Years: A Cohort Analysis.&rdquo;This historical cohort study used claims data from the HealthCare 21 Business Coalition data warehouse, which represents regional employer members with more than 180,000 covered lives. Patients were included if they were 18 to 65 years with non-cancer&ndash;related pain, had continuous enrollment between January 1, 2015, and June 30, 2017, and had one prescription claim during the index year (July 1, 2015, to June 30, 2016).The researchers categorized the 23,951 patients as:<ul>
<li>Chronic users: Those with 90 days of continuous opioid coverage during the index year (3.3%)</li>
<li>Acute users: Those with one opioid fill for &lt;90 days of continuous opioid coverage (25.5%)</li>
<li>Non-opioid users: Those without any opioid prescription (71.2%)</li>
</ul>The median patient age was 46.5 years (standard deviation, 12.3), and more than half (69.1%) were female.Among opioid users, 17.2% of chronic users and 17.5% of acute users had one inpatient hospital stay compared with 6.6% of non-opioid users (P&lt;0.001). At least one emergency department visit was reported in 43.3% of chronic users and 44.9% of acute opioid users compared with 22.2% of non-opioid users (P&lt;0.001).Generalized linear models revealed that chronic ($32,815) and acute ($21,006) opioid users incurred greater total mean healthcare costs compared with non-opioid users ($8,740;&nbsp;P&lt;0.001) over a two-year period (2015-2017).&ldquo;Due to the increased economic burden and healthcare resource utilization associated with opioid use, other pain management approaches should be considered,&rdquo; the researchers concluded. &ldquo;Employer groups and payers may consider coverage of alternative treatment modalities, treatment services for opioid use disorder, and monitoring of opioid utilization.&rdquo;Voelker J, Bartolome L, Singer D, Crawford A, Fortner G, Goldfarb N. Healthcare Resource Utilization and Costs in Chronic and Acute Opioid Users over 2 Years: A Cohort Analysis. Abstract R1. Presented at the AMCP Managed Care &amp; Specialty Pharmacy Annual Meeting, April 23-26; Boston, MA.

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Both Chronic and Acute Opioid Users Have Increased Healthcare Utilization

AMCP 2018

Between 2000 and 2015, deaths from opioid prescriptions more than quadrupled, and evidence of long-term efficacy of opioids for chronic pain is limited. Researchers sought to ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe